Diazepam Pediatric Dose — Sedatives & Anxiolytics
Diazepam is a long-acting benzodiazepine that potentiates GABA-mediated inhibition in the CNS, producing anxiolysis, sedation, muscle relaxation, and anticonvulsant effects. It is used in pediatric practice for a range of indications including anxiety, procedural sedation, muscle spasticity, and seizure management. Its prolonged half-life and active metabolites distinguish it from shorter-acting benzodiazepines and influence dosing frequency with chronic administration.
Pediatric Dosing
| Route | Dose | Frequency |
|---|---|---|
| Oral (PO) | 0.12–0.8 mg/kg/day divided | Every 6 hours; due to long half-life, may dose BID or TID with chronic use |
| Intravenous (IV) | 0.04–0.3 mg/kg/dose | Every 2–6 hours as needed |
For the oral route, the total daily dose of 0.12–0.8 mg/kg/day is divided into individual doses. For a 20 kg child: total daily oral dose = 20 × 0.12 mg/kg/day to 20 × 0.8 mg/kg/day = 2.4–16 mg/day, divided every 6 hours (or BID–TID with chronic use).
For intravenous dosing, a single IV dose for a 20 kg child = 20 × 0.04 mg/kg to 20 × 0.3 mg/kg = 0.8–6 mg/dose, administered every 2–6 hours as clinically indicated. Consult institutional protocol for maximum single-dose limits not specified in the source.
Indications and Clinical Context
Diazepam is indicated in pediatric patients requiring anxiolysis, sedation, or skeletal muscle relaxation. Oral formulations are appropriate for outpatient or longer-term management where a sustained effect is desired; the drug’s long half-life and active metabolite (desmethyldiazepam) allow for less frequent dosing with chronic administration. Intravenous diazepam is reserved for acute settings where rapid onset of sedation or seizure control is necessary, consistent with general benzodiazepine use in emergency and critical care contexts.
When used as part of a sedation strategy in hospitalized pediatric patients, diazepam fits within the broader category of CNS depressants used for procedural or therapeutic sedation. Clinicians should weigh the prolonged duration of action against clinical need, particularly in neonates and young infants who have reduced metabolic capacity and may accumulate active drug.
Administration and Monitoring
Intravenous diazepam should be administered slowly to reduce the risk of respiratory depression, hypotension, and phlebitis; it is not readily compatible with many IV solutions due to its lipophilic nature and may precipitate on dilution. IM administration is generally discouraged due to erratic and painful absorption. Oral formulations are well absorbed and appropriate for ambulatory dosing. When transitioning from IV to oral therapy, the long half-life supports BID or TID scheduling during chronic use.
- Monitor: Respiratory rate, oxygen saturation, level of sedation, and blood pressure, particularly with IV administration.
- Adverse effects: Respiratory depression, excessive sedation, anterograde amnesia, paradoxical agitation (especially in young children), and hypotension.
- Contraindications/Cautions: Use with caution in neonates (benzyl alcohol in some formulations); avoid abrupt discontinuation after prolonged use due to withdrawal risk; caution with concurrent CNS depressants.
- Accumulation risk: Long half-life and active metabolites warrant careful monitoring with repeated dosing or chronic use, particularly in hepatic impairment.
Disclaimer: This article is an educational reference summarizing standard pediatric dosing values. It is not a substitute for clinical judgment. Always verify doses against institutional protocols, the current edition of authoritative references (e.g., Lexicomp, Harriet Lane Handbook, PALS guidelines), the patient’s accurate weight, and any patient-specific factors (renal/hepatic function, allergies, comedications) before administration.